S&P 500 Futures struggle to regain 3,400 amid mixed clues for Trump’s health

S&P 500 Futures consolidate the previous day’s gains around three-week high.
US President Trump leaves hospital feeling “20-years younger” but concerns about breathing capacity probe earlier market optimism.
RBA, Aussie budget to dominate Asian calendar, Fed Chair Powell’s speech, Trump’s COVID-19 update will be the key afterward.

S&P 500 Futures seesaw around 3,390, down 0.07% intraday, during Tuesday’s Asian session. In doing so, the risk barometer part ways from Monday’s upbeat performance that probed the mid-September highs.

Although US President Donald Trump’s departure from the Walter Reed, followed by few tweets from the Republican leader, initially kept the risk-on mood, a recent video from the American leader showed that he is struggling while breathing. Also strengthening doubts over Trump’s health was the recent confirmation from the White House that he will be under 24-hour care and anybody nearing the President will need to wear the PPE kit.

Earlier in the day, the White House blocked the US Food and Drug Administration’s (FDA) stricter guidelines that could have stopped the coronavirus (COVID-19) vaccine from rolling out before the presidential election.

Elsewhere, odds of the soft Brexit are on the hike while US House Speaker Nancy Pelosi and the Treasury Secretary Steve Mnuchin keep struggling to even start the stimulus talks.

Not only the S&P 500 Futures but risk catalysts from Asia-Pacific, like Nikkei 225 and Australia’s ASX 200, also flash mixed signals and probe the market bulls.

Moving on, RBA and Aussie budget will be crucial to watch during Asia while Fed Chairman Jerome Powell’s speech and updates concerning US President Trump will keep the driver’s seat.

Share: Feed news

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.